Join
Live feed
·
INSIDERFilingvia Quantisnow
eXoZymes Inc. logo

Chief Executive Officer Heltzen Michael bought $6,405 worth of shares (855 units at $7.49) and was granted 8,841 shares, decreasing direct ownership by 6% to 13,853 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EXOZ· eXoZymes Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EXOZ (eXoZymes Inc.) and more on Quantisnow.